Clinical Trials Directory

Trials / Completed

CompletedNCT06606184

Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Chang Gung University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial was to access the benefits of a 12-week home-based pulmonary rehabilitation regimen on pulmonary function recovery in post-liver transplant patients. The main questions it aims to answer are: Does pulmonary rehabilitation facilitate pulmonary muscle strength recovery? Does the intervention improve pulmonary function and reduce dyspnea sensation? Participants performed: Inspiratory muscle training twice a day for 12 weeks after discharged from the hospital Upper limb resistive training Lower limb exercise

Detailed description

Patients undergoing liver transplantation often face significant challenges related to pulmonary rehabilitation. Although postoperative rehabilitation has been extensively studied, the specific role of pulmonary rehabilitation programs has received limited attention. This study aims to evaluate the efficacy of a home-based pulmonary rehabilitation program in improving respiratory function recovery among post-liver transplant patients. The training group participated in a 12-week pulmonary rehabilitation program post-discharge, emphasizing respiratory muscle and exercise training, while the control group received standard care, which included traditional rehabilitation.

Conditions

Interventions

TypeNameDescription
PROCEDUREInspiratory muscle TrainingParticipants underwent a 12-week program consisting of inspiratory muscle training twice daily, incentive spirometry three times daily, and upper limb exercises along with marching in place for 30 minutes.
PROCEDURERoutine CareParticipants received routine care, which included encouragement to use incentive spirometry three times daily.

Timeline

Start date
2022-01-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2024-09-20
Last updated
2024-09-20

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06606184. Inclusion in this directory is not an endorsement.